Eris Lifesciences has confirmed the dematerialization of securities for the quarter ended September 30, 2025. The confirmation, received from MUFG Intime India Private Limited, indicates that securities received for dematerialization have been processed and confirmed with the depositories. All related security certificates have been duly mutilated and cancelled, with depositories registered as owners.
Dematerialization Confirmation
Eris Lifesciences confirms the successful processing of securities received for dematerialization during the quarter ending September 30, 2025. This confirmation aligns with regulatory requirements for depositories and participants. The confirmation was received from MUFG Intime India Private Limited, the Registrar and Share Transfer Agent (RTA) for Eris Lifesciences.
Regulatory Compliance
The confirmation ensures compliance with regulations concerning the dematerialization process. MUFG Intime India Private Limited has verified and confirmed the securities, ensuring all procedures are followed correctly.
Details of the Process
As part of the process, security certificates received for dematerialization have been confirmed, and subsequently mutilated and cancelled. The depositories have been registered as the new owners.
Source: BSE
